Current perspectives on vaccines and therapeutics for Lassa Fever

Simple item page
dc.contributor.authorWarner, Bryce M.
dc.contributor.authorSafronetz, David J.
dc.contributor.authorStein, Derek
dc.date.accessioned2025-01-21T20:50:32Z
dc.date.available2025-01-21T20:50:32Z
dc.date.issued2024-12-19
dc.date.updated2025-01-01T04:24:51Z
dc.description.abstractAbstract Lassa virus, the cause of deadly Lassa fever, is endemic in West Africa, where thousands of cases occur on an annual basis. Nigeria continues to report increasingly severe outbreaks of Lassa Fever each year and there are currently no approved vaccines or therapeutics for the prevention or treatment of Lassa Fever. Given the high burden of disease coupled with the potential for further escalation due to climate change the WHO has listed Lassa virus as a priority pathogen with the potential to cause widespread outbreaks. Several candidate vaccines have received support and have entered clinical trials with promising early results. This review focuses on the current state of vaccine and therapeutic development for LASV disease and the potential of these interventions to advance through clinical trials. The growing burden of LASV disease in Africa highlights the importance of advancing preclinical and clinical testing of vaccines and therapeutics to respond to the growing threat of LASV disease.
dc.identifier.citationVirology Journal. 2024 Dec 19;21(1):320
dc.identifier.doi10.1186/s12985-024-02585-7
dc.identifier.urihttp://hdl.handle.net/1993/38841
dc.language.isoeng
dc.language.rfc3066en
dc.publisherBMC
dc.rights.holderThe Author(s)
dc.subjectLassa virus
dc.subjectLassa fever
dc.subjectVaccines
dc.subjectTherapeutics
dc.subjectAntivirals
dc.subjectAnimal models
dc.subjectConvalescent plasma
dc.subjectMonoclonal antibodies
dc.titleCurrent perspectives on vaccines and therapeutics for Lassa Fever
dc.typeJournal Article
local.author.affiliationRady Faculty of Health Sciences::Max Rady College of Medicine::Department of Medical Microbiology and Infectious Diseases
oaire.citation.issue320
oaire.citation.titleVirology Journal
oaire.citation.volume21
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
12985_2024_Article_2585.pdf
Size:
1.23 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
770 B
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
University of Manitoba Scholarship